Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults
Abstract The therapeutic effects of B. coagulans Unique IS2 have been well established in children with irritable bowel syndrome (IBS), but its efficacy in adults remain under reported. Thus, in this study the efficacy of B. coagulans Unique IS2 in the management of IBS symptoms in adults was invest...
Guardado en:
Autores principales: | Ratna Sudha Madempudi, Jayesh J. Ahire, Jayanthi Neelamraju, Anirudh Tripathi, Satyavrat Nanal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2e001c9759af472d86df199efb9057b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro
por: Jensen GS, et al.
Publicado: (2017) -
Functional analysis of the ComK protein of Bacillus coagulans.
por: Ákos T Kovács, et al.
Publicado: (2013) -
Formulation and evaluation of Bacillus coagulans-loaded hypromellose mucoadhesive microspheres
por: Alli SMA
Publicado: (2011) -
Efficacy of probiotic adjuvant therapy for irritable bowel syndrome in children: A systematic review and meta-analysis.
por: Hua-Lan Xu, et al.
Publicado: (2021) -
Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Xiufang Cui, et al.
Publicado: (2021)